Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Seattle, Washington

A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia